Navigation Links
Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
Date:1/29/2013

ties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of such product candidates, the absence of guarantee that the product candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives, the Group's ability to benefit from external growth opportunities, trends in exchange rates and prevailing interest rates, the impact of cost containment policies and subsequent changes thereto, the average number of shares outstanding as well as those discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in Sanofi's annual report on Form 20-F for the year ended December 31, 2011. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.


Contacts:Media RelationsInvestor RelationsSarah ConnorsKristen GalfettiTel.: 617.252.7639Tel.: 1 908 981.5560Sarah.Connors@sanofi.comir@sanofi.com


'/>"/>
SOURCE Sanofi
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
2. Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts
3. Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes
4. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
5. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
6. Sanofi Pasteur to add 2D barcode to six more vaccines
7. Sanofi US Launches Collaborate Activate Innovation Challenge
8. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
9. New Website IVT Network Launches Today for Validation and Compliance Professionals
10. ViroPharma Launches Novel Campaign to Illustrate the Emotional Burden of Hereditary Angioedema
11. Sequent Medical, Inc. Launches VIA Microcatheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... MEADOWS, N.Y. , Dec. 15, 2014 ... the SPL (Structured Product Labeling) markup language standard, content ... the understanding and skills to work with the standard. ... a series of three webinars on the benefits and ... three one-hour webinars will be facilitated by Howard ...
(Date:12/14/2014)...  ChartSpan, a consumer platform for patients managing healthcare ... medical app in the United States ... ChartSpan is an iPhone and iPad app ... send electronic healthcare records. The product was built by ... waiting for the healthcare system to deliver on the ...
(Date:12/13/2014)... Dec 12, 2014 Mindray Medical International Limited ... manufacturer and marketer of medical devices worldwide, today announced ... shareholders held in Hong Kong ... Mindray shareholders voted to re-elect incumbent directors Li Xiting ... Mindray,s shareholders did not re-elect Peter Wan ...
Breaking Medicine Technology:Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 2Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 3ChartSpan Becomes The Most Downloaded Medical App in America 2ChartSpan Becomes The Most Downloaded Medical App in America 3Mindray Announced Shareholder Resolutions Post 2014 Annual General Meeting 2
... International Holdings , Inc. (NYSE Amex: BONE ... graft material and antimicrobial coatings for medical applications, has ... national investor relations firm, to develop and implement a ... strengthen its relationships with the investment community. ...
... 1, 2012   IntraOp Medical Corporation   (OTC: IOPD) ... dismissed the patent nullification case that IntraOp Medical had ... for a mobile IOERT linear accelerator with "straight through" ... slight clarification. IntraOp Medical,s European Patent ...
Cached Medicine Technology:Bacterin Retains Hayden IR to Develop Strategic Investor Relations Program 2Bacterin Retains Hayden IR to Develop Strategic Investor Relations Program 3Bacterin Retains Hayden IR to Develop Strategic Investor Relations Program 4IntraOp Medical wins Patent Defense Suit Protecting Their Intellectual Property 2IntraOp Medical wins Patent Defense Suit Protecting Their Intellectual Property 3
(Date:12/15/2014)... researchers have just published an important new report on ... mesothelioma. Surviving Mesothelioma has just posted an article on ... read it now. , Doctors at Harvard, MIT, ... Langone Medical Center performed complete genetic analyses on 22 ... to pinpoint the genes that are most likely to ...
(Date:12/15/2014)... Street Dental Team ( http://www.MainStreetDentalTeam.com ), Unionville’s first full-time ... providing evidence on the impact of 100% pure fruit ... enough evidence already exists showing a negative link between ... the onset of tooth decay. One question that has ... fruit juice, meaning it is completely natural with no ...
(Date:12/15/2014)... 2014 SIMpalm, a leading mobile ... for iPhone for its client, which allows users to ... company, specialized in finding the right wine. At ... uses combined sensory, chemistry and wine information. All this ... “wine fingerprint.” Those wines that are close counterparts to ...
(Date:12/15/2014)... 2014 Health Dialog, a leading ... that it has received Patient Oriented Accreditation from ... its Disease Management (DM) Programs for asthma, congestive ... heart disease and diabetes. This marks the 12th ... Dialog’s Disease Management (DM) Programs, reaffirming Health Dialog’s ...
(Date:12/15/2014)... (HealthDay News) -- Expert pilots process visual information more ... make better decisions during landings, a new study shows. ... for pilots to master, and 36 percent of all ... during final approach and landing. Researchers monitored the ... experienced pilots while they were at the controls of ...
Breaking Medicine News(10 mins):Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Study Shows Why Expert Pilots Are Experts 2
... ... and provides healthy lifestyle message. , ... (Vocus) April 1, 2010 -- AthletiCo Physical Therapy and Occupational Therapy has signed a ... the 7th Inning Stretch Fan Cam for the 2010 through 2012 Major League Baseball (MLB) ...
... they know how cytomegalovirus continues to re-infect people , THURSDAY, ... how a virus known as cytomegalovirus (CMV), which infects up ... re-infects people again and again even though their immune systems ... always make people ill, but certain people, such as newborns ...
... with hepatitis C are fine for patients with the ... News) -- Every year, hundreds of kidneys are thrown ... but they could help many hepatitis C-infected patients waiting ... fact, since 1995, more than 3,500 kidneys infected with ...
... a cell wall and fuse with it could offer researchers ... of individual cells. Everything from signals generated as cells ... to medication could be monitored for up to a week, ... are so destructive they usually only allow a few hours ...
... of cancer cells to resist treatment with either targeted ... result from a transient state of reversible drug "tolerance." ... journal Cell and is receiving early online ... Center report finding small populations of drug-tolerant cells from ...
... Dr. Daniel D. Von Hoff, Physician-in-Chief for the Translational ... the American Society of Clinical Oncology (ASCO) for his cancer ... 2010 David A. Karnofsky Memorial Award and Lecture at ASCO,s ... Chicago. ASCO will present the award to Dr. Von ...
Cached Medicine News:Health News:AthletiCo Physical and Occupational Therapy and Chicago White Sox Partner for 7th Inning Stretch Fan Cam 2Health News:AthletiCo Physical and Occupational Therapy and Chicago White Sox Partner for 7th Inning Stretch Fan Cam 3Health News:Demystifying a Common, Persistent Virus 2Health News:Hundreds of Donor Kidneys Tossed Away Each Year 2Health News:Hundreds of Donor Kidneys Tossed Away Each Year 3Health News:Nanoscale 'stealth' probe slides into cell walls seamlessly, say Stanford engineers 2Health News:Nanoscale 'stealth' probe slides into cell walls seamlessly, say Stanford engineers 3Health News:Treatment resistance in some cancer cells may be reversible 2Health News:TGen Physician-In-Chief Dr. Daniel D. Von Hoff wins ASCO award 2
Rheumatoid factor calibrator (Latex enhancedimmunoturbidimetric)...
Fructosamine Calibrator...
CRP high sensitivity calibrator series...
CRP Calibrator...
Medicine Products: